HCA Healthcare Granted (in shares) remained flat by 0.0% to $82.45 in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.0%, from $76.36 to $82.45. Over 4 years (FY 2021 to FY 2025), Granted (in shares) shows an upward trend with a 17.2% CAGR.
Trends in share grants help investors model future share count dilution and assess the intensity of management's equity-based compensation.
This metric represents the aggregate number of shares granted under specific share-based payment arrangements, often use...
Standard disclosure for companies with active equity compensation programs.
other_share_based_compensation_arrangements_by_share_bas_099e66| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $174.98 | $236.00 | $253.49 | $305.44 | $329.80 |
| YoY Change | — | +34.9% | +7.4% | +20.5% | +8.0% |